Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin

Regulatory Peptides

Volumn 161, Issue 1-3, 2010, Pages 8-14

  Sánchez Margalet, Víctor ^a   González Yanes, Carmen ^a   Najib, Souad ^a   Santos Álvarez, José ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Chromogranin A; Counterregulatory hormone; Insulin action; Insulin resistance; Pancreastatin; Signal transduction

Indexed keywords

CALCIUM; CHROMOGRANIN A; GLUCOSE; GLYCINE; GLYCOGEN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PANCREASTATIN; PHOSPHOLIPASE C BETA; PROTEIN KINASE C; SERINE;

ADIPOCYTE; CELL GROWTH; ENERGY METABOLISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; HORMONE ACTION; HUMAN; INSULIN RESISTANCE; LIPOLYSIS; LIVER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SECRETORY GRANULE; SIGNAL TRANSDUCTION; SYMPATHETIC TONE;

ANIMALS; CHROMOGRANIN A; HUMANS; INSULIN; INSULIN RESISTANCE; MODELS, BIOLOGICAL; PANCREATIC HORMONES; SIGNAL TRANSDUCTION;

EID: 77950337737     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.02.005     Document Type: Review

References (92)

1. Tatemoto K., Efendic S., Mutt V., Makk G., Feistner G.J., Barchas J.D. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986, 324:476-478.
2. Efendic S., Tatemoto K., Mutt V., Quan C., Chang D., Ostenson C.G. Pancreastatin and islet hormone release. Proc Natl Acad Sci USA 1987, 84:7257-7260.
3. Eiden L.E. Is chromogranin a prohormone?. Nature 1987, 325:301.
4. Huttner W.B., Benedum U.M. Chromogranin A and pancreastatin. Nature 1987, 325:305.
5. Konecki D.S., Benedum U.M., Gerdes H.H., Huttner W.B. The primary structure of human chromogranin A and pancreastatin. J Biol Chem 1987, 262:17026-17030.
6. Schmidt W.E., Siegel E.G., Kratzin H., Creutzfeldt W. Isolation and primary structure of tumor-derived peptides related to human pancreastatin and chromogranin A. Proc Natl Acad Sci U S A 1988, 85:8231-8235.
7. Blaschko H., Comline R.S., Schneider F.H., Silver M., Smith A.D. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 1967, 215:58-59.
8. Smith A.D., Winkler H. Purification and properties of an acidic protein from chromaffin granules of bovine adrenal medulla. Biochem J 1967, 103:483-492.
9. Helle K.B., Angeletti R.H. Chromogranin A: a multipurpose prohormone?. Acta Physiol Scand 1994, 152:1-10.
10. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin: further evidence for its consideration as a regulatory peptide. J Mol Endocrinol 1996, 16:1-8.
11. Tatemoto K., Mutt V. Chemical determination of polypeptide hormones. Proc Natl Acad Sci U S A 1978, 75:4115-4119.
12. Ostenson C.G., Sandler S., Efendic S. Effects of porcine pancreastatin on secretion and biosynthesis of insulin and glucose oxidation of isolated rat pancreatic islets. Pancreas 1989, 4:441-446.
13. Sanchez-Margalet V., Calvo J.R., Lucas M., Goberna R. Pancreastatin and its 33-49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo. Gen Pharmacol 1992, 23:637-638.
14. Ahren B., Lindskog S., Tatemoto K., Efendic S. Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice. Diabetes 1988, 37:281-285.
15. Efendic S., Tatemoto K., Mutt V., Quan C., Chang D., Ostenson C.G. Pancreastatin and islet hormone release. Proc Natl Acad Sci USA 1987, 84:7257-7260.
16. Miyasaka K., Funakoshi A., Kitani K., Tamamura H., Funakoshi S., Fujii N. Inhibitory effect of pancreastatin on pancreatic exocrine secretions. Pancreastatin inhibits central vagal nerve stimulation. Gastroenterology 1990, 99:1751-1756.
17. Lewis J.J., Zdon M.J., Adrian T.E., Modlin I.M. Pancreastatin: a novel peptide inhibitor of parietal cell secretion. Surgery 1988, 104:1031-1036.
18. Fasciotto B.H., Gorr S.U., DeFranco D.J., Levine M.A., Cohn D.V. Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture. Endocrinology 1989, 125:1617-1622.
19. Sánchez-Margalet V., Santos-Alvarez J., Gonzalez-Yanes C., Najib S. Pancreastatin: Biological effects and mechanisms of action. Adv Exp Med Biol 2000, 482:247-262.
20. Carmen G.Y., Víctor S.M. Signalling mechanisms regulating lipolysis. Cell Signal 2006, 18:401-408.
21. Hutton J.C., Nielsen E., Karsten W. The molecular cloning of the chromogranin A-like precursor of beta-granin and pancreastatin from the endocrine pancreas. FEBS Lett 1988, 236:269-274.
22. Sekiya K., Ghatei M.A., Minamino N., Bretherton-Watt D., Matsuo H., Bloom S.R. Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma. FEBS Lett 1988, 228:153-156.
23. Funakoshi S., Tamamura H., Ohta M., Yoshizawa K., Funakoshi A., Miyasaka K., Tateishi K., Tatemoto K., Nakano I., Yajima H., Fujii N. Isolation and characterization of a tumor-derived human pancreastatin-related protein. Biochem Biophys Res Commun 1989, 164:141-148.
24. Tamamura H., Ohta M., Yoshizawa K., Ono Y., Funakoshi A., Miyasaka K., Tateishi K., Jimi A., Yajima H., Fujii N., Funakoshi S. Isolation and characterization of a tumor-derived human protein related to chromogranin A and its in vitro conversion to human pancreastatin-48. Eur J Biochem 1990, 191:33-39.
25. Curry W.J., Johnston C.F., Shaw C., Buchanan K.D. Distribution and partial characterisation of immunoreactivity to the putative C-terminus of rat pancreastatin. Regul Pept 1990, 30:207-219.
26. Håkanson R., Ding X.Q., Norlén P., Chen D. Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach. Gastroenterology 1995, 108:1445-1452.
27. Kitayama N., Tateishi K., Funakoshi A., Miyasaka K., Shimazoe T., Kono A., Iwamoto N., Matsuoka Y. Pancreastatin molecular forms in normal human plasma. Life Sci 1994, 54:1571-1578.
28. Watkinson A., Rogers M., Dockray G.J. Post-translational processing of chromogranin A: differential distribution of phosphorylated variants of pancreastatin and fragments 248-313 and 297-313 in bovine pancreas and ileum. Biochem J 1993, 295:649-654.
29. Curry W.J., Johnston C.F., Hutton J.C., Arden S.D., Rutherford N.G., Shaw C., Buchanan K.D. The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera. Histochemistry 1991, 96:531-538.
30. Metz-Boutigue M.H., Garcia-Sablone P., Hogue-Angeletti R., Aunis D. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 1993, 217:247-257.
31. Leduc R., Hendy G.N., Seidah N.G., Chrétien M., Lazure C. Fragmentation of bovine chromogranin A by plasma kallikrein. Life Sci 1990, 46:1427-1433.
32. Watkinson A., Jönsson A.C., Davison M., Young J., Lee C.M., Moore S., Dockray G.J. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla. Biochem J 1991, 276:471-479.
33. Arden S.D., Rutherford N.G., Guest P.C., Curry W.J., Bailyes E.M., Johnston C.F., Hutton J.C. The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2. Biochem J 1994, 298:521-528.
34. O'Connor D.T., Cadman P.E., Smiley C., Salem R.M., Rao F., Smith J., Funk S.D., Mahata S.K., Mahata M., Wen G., Taupenot L., Gonzalez-Yanes C., Harper K.L., Henry R.R., Sanchez-Margalet V. Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism. J Clin Endocrinol Metab 2005, 90:5414-5425.
35. Eskeland N.L., Zhou A., Dinh T.Q., Wu H., Parmer R.J., Mains R.E., O'Connor D.T. Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. J Clin Invest 1996, 98:148-156.
36. Prigge S.T., Mains R.E., Eipper B.A., Amzel L.M. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell Mol Life Sci 2000, 57:1236-1259.
37. Yasothornsrikul S., Greenbaum D., Medzihradszky K.F., Toneff T., Bundey R., Miller R., Schilling B., Petermann I., Dehnert J., Logvinova A., Goldsmith P., Neveu J.M., Lane W.S., Gibson B., Reinheckel T., Peters C., Bogyo M., Hook V. Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc Natl Acad Sci USA 2003, 100:9590-9595.
38. Biswas N., Rodriguez-Flores J.L., Courel M., Gayen J.R., Vaingankar S.M., Mahata M., Torpey J.W., Taupenot L., O'Connor D.T., Mahata S.K. Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides. Endocrinology 2009, 150:3547-3557.
39. Sánchez V., Calvo J.R., Goberna R. Glycogenolytic effect of pancreastatin in the rat. Biosci Rep 1990, 10:87-91.
40. Sánchez-Margalet V., Calvo J.R., Goberna R. Glucogenolytic and hyperglycemic effect of 33-49 C-terminal fragment of pancreastatin in the rat in vivo. Horm Metab Res 1992, 24:455-457.
41. Sánchez V., Lucas M., Calvo J.R., Goberna R. Glycogenolytic effect of pancreastatin in isolated rat hepatocytes is mediated by a cyclic-AMP-independent Ca(2+)-dependent mechanism. Biochem J 1992, 284:659-662.
42. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin increases free cytosolic Ca2+ in rat hepatocytes, involving both pertussis-toxin-sensitive and -insensitive mechanisms. Biochem J 1993, 294:439-442.
43. Sánchez-Margalet V., Goberna R. Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes. Regul Pept 1994, 51:215-220.
44. Smith J.P., Kramer S., Bagheri S. Effects of pancreastatin (24-49) on growth of normal pancreas and pancreatic cancer. Pancreas 1991, 6:551-557.
45. Sjöholm A., Funakoshi A., Efendić S., Ostenson C.G., Hellerström C. Long term inhibitory effects of pancreastatin and diazepam binding inhibitor on pancreatic beta-cell deoxyribonucleic acid replication, polyamine content, and insulin secretion. Endocrinology 1991, 128:3277-3282.
46. Sánchez-Margalet V., González-Yanes C., Najib S. Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cells. J Hepatol 2001, 35:80-85.
47. Sánchez-Margalet V., González-Yanes C. Pancreastatin inhibits insulin action in rat adipocytes. Am J Physiol 1998, 275:E1055-E1060.
48. Waldbillig D., Desautels M. Characterization of norepinephrine-stimulated protein synthesis in rat brown adipocytes. Am J Physiol 1992, 263:R1003-R1012.
49. Ghorbani M., Claus T.H., Himms-Hagen J. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Biochem Pharmacol 1997, 54:121-131.
50. Gerhardt C.C., Gros J., Strosberg A.D., Issad T. Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation. Mol Pharmacol 1999, 55:255-262.
51. Gutkind J.S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J Biol Chem 1998, 273:1839-1842.
52. Sale E.M., Atkinson P.G., Sale G.J. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J 1995, 14:674-684.
53. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
54. Hardie L.J., Guilhot N., Trayhurn P. Regulation of leptin production in cultured mature white adipocytes. Horm Metab Res 1996, 28:685-689.
55. Leroy P., Dessolin S., Villageois P., Moon B.C., Friedman J.M., Ailhaud G., Dani C. Expression of ob gene in adipose cells. Regulation by insulin. J Biol Chem 1996, 271:2365-2368.
56. Rentsch J., Chiesi M. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett 1996, 379:55-59.
57. Trayhurn P., Duncan J.S., Hoggard N., Rayner D.V. Regulation of leptin production: a dominant role for the sympathetic nervous system?. Proc Nutr Soc 1998, 57:413-419.
58. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994, 79:1147-1156.
59. Boss O., Hagen T., Lowell B.B. Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 2000, 49:143-156.
60. Gonzalez-Yanes C., Sanchez-Margalet V. Pancreastatin, a chromogranin A-derived peptide, inhibits leptin and enhances UCP-2 expression in isolated rat adipocytes. Cell Mol Life Sci 2003, 60:2749-2756.
61. Sánchez-Margalet V., Valle M., Goberna R. Receptors for pancreastatin in rat liver membranes: molecular identification and characterization by covalent cross-linking. Mol Pharmacol 1994, 46:24-29.
62. Sánchez-Margalet V., González-Yanes C., Santos-Alvarez J., Najib S. Characterization of pancreastatin receptor and signaling in rat HTC hepatoma cells. Eur J Pharmacol 2000, 397:229-235.
63. González-Yanes C., Santos-Alvarez J., Sánchez-Margalet V. Characterization of pancreastatin receptors and signaling in adipocyte membranes. Biochim Biophys Acta 1999, 1451:153-162.
64. González-Yanes C., Santos-Alvarez J., Sánchez-Margalet V. Pancreastatin, a chromogranin A-derived peptide, activates Galpha(16) and phospholipase C-beta(2) by interacting with specific receptors in rat heart membranes. Cell Signal 2001, 13:43-49.
65. Sánchez-Margalet V., Santos-Alvarez J. Solubilization and molecular characterization of active pancreastatin receptors from rat liver membranes. Endocrinology 1997, 138:1712-1718.
66. Santos-Alvarez J., Sánchez-Margalet V. Affinity purification of pancreastatin receptor-Gq/11 protein complex from rat liver membranes. Arch Biochem Biophys 2000, 378:151-156.
67. Sánchez-Margalet V., Santos-Alvarez J., Díaz-Troya S. Purification of pancreastatin receptor from rat liver membranes. Methods Mol Biol 2003, 228:187-194.
68. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin action in the liver: dual coupling to different G proteins. Cell Signal 1996, 8:9-12.
69. Santos-Alvarez J., González-Yanes C., Sánchez-Margalet V. Pancreastatin receptor is coupled to a guanosine triphosphate-binding protein of the G(q/11)alpha family in rat liver membranes. Hepatology 1998 Feb, 27(2):608-614.
70. Santos-Alvarez J., Sánchez-Margalet V. Pancreastatin activates beta3 isoform of phospholipase C via G(alpha)11 protein stimulation in rat liver membranes. Mol Cell Endocrinol 1998, 143:101-106.
71. Santos-Alvarez J., Sánchez-Margalet V. G protein G alpha q/11 and G alpha i1, 2 are activated by pancreastatin receptors in rat liver: studies with GTP-gamma 35S and azido-GTP-alpha-32P. J Cell Biochem 1999, 73:469-477.
72. Sánchez-Margalet V., Goberna R. Pancreastatin activates pertussis toxin-sensitive guanylate cyclase and pertussis toxin-insensitive phospholipase C in rat liver membranes. J Cell Biochem 1994, 55:173-181.
73. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin increases free cytosolic Ca2+ in rat hepatocytes, involving both pertussis-toxin-sensitive and -insensitive mechanisms. Biochem J 1993, 294:439-442.
74. Sánchez V., Lucas M., Calvo J.R., Goberna R. Glycogenolytic effect of pancreastatin in isolated rat hepatocytes is mediated by a cyclic-AMP-independent Ca(2+)-dependent mechanism. Biochem J 1992, 284:659-662.
75. Sánchez-Margalet V., Lucas M., Goberna R. Pancreastatin activates protein kinase C by stimulating the formation of 1, 2-diacylglycerol in rat hepatocytes. Biochem J 1994, 303:51-54.
76. Sánchez-Margalet V. Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells. Diabetologia 1999, 42:317-325.
77. Gonzalez-Yanes C., Santos-Alvarez J., Sanchez-Margalet V. Metabolic effects of the chromogranin A-derived peptide, pancreastatin, in the adipocyte. Adipocyte 2005, 1:229-238.
78. González-Yanes C., Sánchez-Margalet V. Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk. Diabetes 2000, 49:1288-1294.
79. González-Yanes C., Sánchez-Margalet V. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes. Biochem Biophys Res Commun 2001, 289:282-287.
80. González-Yanes C., Sánchez-Margalet V. Pancreastatin, a chromogranin A-derived peptide, activates protein synthesis signaling cascade in rat adipocytes. Biochem Biophys Res Commun 2002, 299:525-531.
81. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., Finkenzeller G., Marmé D., Rapp U.R. Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 1993, 364:249-252.
82. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., White M.F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991, 352:73-77.
83. Cheatham B., Kahn C.R. Insulin action and the insulin signaling network. Endocr Rev 1995, 16:117-142.
84. Cohen P., Alessi D.R., Cross D.A. PDK1, one of the missing links in insulin signal transduction?. FEBS Lett 1997, 410:3-10.
85. Paz K., Hemi R., LeRoith D., Karasik A., Elhanany E., Kanety H., Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 1997, 272:29911-29918.
86. Ueki K., Yamamoto-Honda R., Kaburagi Y., Yamauchi T., Tobe K., Burgering B.M., Coffer P.J., Komuro I., Akanuma Y., Yazaki Y., Kadowaki T. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 1998, 273:5315-5322.
87. Funakoshi A., Tateishi K., Shinozaki H., Matsumoto M., Wakasugi H. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM). Regul Pept 1990, 30:159-164.
88. Sánchez-Margalet V., Valle M., Lobón J.A., Maldonado A., Escobar-Jimenez F., Oliván J., Pérez-Cano R., Goberna R. Increased plasma pancreastatin-like immunoreactivity levels in non-obese patients with essential hypertension. J Hypertens 1995, 13:251-258.
89. Sánchez-Margalet V., Valle M., Lobón J.A., Escobar-Jiménez F., Pérez-Cano R., Goberna R. Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension. Neuropeptides 1995, 29:97-101.
90. Sánchez-Margalet V., Lobón J.A., González A., Fernández-Soto M.L., Escobar-Jiménez F., Goberna R. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels. Diab Care 1998, 21:1951-1954.
91. Mahapatra N.R., O'Connor D.T., Vaingankar S.M., Hikim A.P., Mahata M., Ray S., Staite E., Wu H., Gu Y., Dalton N., Kennedy B.P., Ziegler M.G., Ross J., Mahata S.K. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 2005, 115:1942-1952.
92. Gayen J.R., Saberi M., Schenk S., Biswas N., Vaingankar S.M., Cheung W.W., Najjar S.M., ÓConnor D.T., Bandyopadhyay, Mahata S.K. A novel pathway of insulin sensitivity in chromogranin A null mice. A crucial role for pancreastatin in glucose homeostasis. J Biol Chem 2009, 284:28498-28509.